Viewing Study NCT00000920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-05-02 @ 1:46 PM
Study NCT ID: NCT00000920
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Pregnancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pregnancy View
None Drug Therapy, Combination View
None Zidovudine View
None Pregnancy Complications View
None Ritonavir View
None Lamivudine View
None Saquinavir View
None Anti-HIV Agents View